An upregulation of MMP-9 is associated with a disruption of the blood–brain barrier (BBB) and neuroinflammation, which is a risk factor for brain inflammatory disorders, neurodegenerative diseases, cardiovascular diseases, and diabetes [23,24,25,26]. The gene discussed is MMP9; the disease is neurodegenerative disease.